Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes
The natural compound, curcumin (CUR), possesses several pharmacological properties, including p300-specific histone acetyltransferase (HAT) inhibitory activity. In our previous study, we demonstrated that CUR could prevent the development of cardiac hypertrophy by inhibiting p300-HAT activity. Other...
Saved in:
Main Authors: | Yoichi Sunagawa (Author), Masafumi Funamoto (Author), Shogo Sono (Author), Kana Shimizu (Author), Satoshi Shimizu (Author), Mai Genpei (Author), Yusuke Miyazaki (Author), Yasufumi Katanasaka (Author), Eriko Morimoto (Author), Morio Ueno (Author), Maki Komiyama (Author), Hideaki Kakeya (Author), Hiromichi Wada (Author), Koji Hasegawa (Author), Tatsuya Morimoto (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes
by: Yoichi Sunagawa, et al.
Published: (2021) -
Optimal Dose-Setting Study of Curcumin for Improvement of Left Ventricular Systolic Function After Myocardial Infarction in Rats
by: Yoichi Sunagawa, et al.
Published: (2014) -
Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
by: Masafumi Funamoto, et al.
Published: (2022) -
The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2-GATA4 Signaling Pathway
by: Kana Shimizu, et al.
Published: (2021) -
Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease
by: Masafumi Noguchi, et al.
Published: (2020)